Albert David (ALBERTDAVD) | Financial Analysis & Statements
Albert David Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
705.7M
Gross Profit
452.9M
64.18%
Operating Income
-130.4M
-18.48%
Net Income
79.4M
11.25%
EPS (Diluted)
₹13.91
Balance Sheet Metrics
Total Assets
5.1B
Total Liabilities
1.2B
Shareholders Equity
3.9B
Debt to Equity
0.30
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Albert David Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.4B | 3.6B | 3.4B | 3.1B | 2.5B |
| Cost of Goods Sold | 1.2B | 1.3B | 1.3B | 1.2B | 880.3M |
| Gross Profit | 2.2B | 2.3B | 2.1B | 1.9B | 1.6B |
| Gross Margin % | 65.5% | 64.4% | 63.0% | 62.4% | 64.3% |
| Operating Expenses | |||||
| Research & Development | 28.9M | 19.5M | 19.0M | 16.0M | 15.3M |
| Selling, General & Administrative | 756.2M | 707.4M | 661.7M | 512.3M | 399.5M |
| Other Operating Expenses | 76.0M | 61.6M | 58.1M | 48.2M | 56.2M |
| Total Operating Expenses | 861.1M | 788.5M | 738.8M | 576.5M | 471.0M |
| Operating Income | -28.1M | 410.5M | 365.4M | 321.5M | 110.7M |
| Operating Margin % | -0.8% | 11.4% | 10.7% | 10.3% | 4.5% |
| Non-Operating Items | |||||
| Interest Income | 37.5M | 40.7M | 33.2M | 34.4M | 31.6M |
| Interest Expense | 3.0M | 2.1M | 3.4M | 3.9M | 5.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 252.3M | 972.9M | 507.4M | 473.0M | 274.4M |
| Income Tax | 80.3M | 218.7M | 145.6M | 120.4M | 53.0M |
| Effective Tax Rate % | 31.8% | 22.5% | 28.7% | 25.5% | 19.3% |
| Net Income | 172.0M | 754.2M | 361.7M | 352.6M | 221.4M |
| Net Margin % | 5.0% | 20.9% | 10.6% | 11.3% | 9.0% |
| Key Metrics | |||||
| EBITDA | 133.1M | 580.5M | 558.0M | 452.0M | 230.6M |
| EPS (Basic) | ₹30.14 | ₹132.15 | ₹63.39 | ₹61.78 | ₹38.80 |
| EPS (Diluted) | ₹30.14 | ₹132.15 | ₹63.39 | ₹61.78 | ₹38.80 |
| Basic Shares Outstanding | 5707162 | 5707162 | 5707162 | 5707162 | 5707162 |
| Diluted Shares Outstanding | 5707162 | 5707162 | 5707162 | 5707162 | 5707162 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Albert David Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.2M | 54.4M | 14.5M | 22.8M | 30.8M |
| Short-term Investments | 2.4B | 2.8B | 2.0B | 1.7B | 1.5B |
| Accounts Receivable | 273.7M | 293.3M | 303.3M | 250.0M | 194.9M |
| Inventory | 639.0M | 436.1M | 506.8M | 391.8M | 357.5M |
| Other Current Assets | 84.5M | 49.0M | 49.3M | 50.7M | 7.0M |
| Total Current Assets | 3.5B | 3.7B | 3.0B | 2.5B | 2.2B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 100.5M | 92.7M | 88.3M | 96.6M | 90.4M |
| Goodwill | 12.6M | 18.5M | 24.6M | 38.7M | 14.7M |
| Intangible Assets | 12.6M | 18.5M | 24.6M | 38.7M | 14.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 6.2M | 24.0M | 45.9M | 27.5M | 4.5M |
| Total Non-Current Assets | 1.6B | 1.3B | 1.2B | 1.5B | 1.2B |
| Total Assets | 5.1B | 5.0B | 4.2B | 4.0B | 3.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 375.6M | 339.5M | 321.4M | 303.8M | 246.7M |
| Short-term Debt | 109.9M | 27.2M | 47.0M | 45.5M | 12.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 30.3M | 56.9M | 33.7M | 32.8M | 28.0M |
| Total Current Liabilities | 1.0B | 990.5M | 989.4M | 1.1B | 805.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 13.3M | 6.0M | 6.2M | 11.1M | 3.9M |
| Deferred Tax Liabilities | 63.2M | 32.8M | 0 | 4.0M | 9.7M |
| Other Non-Current Liabilities | - | - | 52.0K | - | - |
| Total Non-Current Liabilities | 147.5M | 159.6M | 128.8M | 144.3M | 164.1M |
| Total Liabilities | 1.2B | 1.2B | 1.1B | 1.2B | 970.0M |
| Equity | |||||
| Common Stock | 57.1M | 57.1M | 57.1M | 57.1M | 57.1M |
| Retained Earnings | 2.5B | 2.4B | 1.7B | 1.3B | 1.0B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.9B | 3.8B | 3.1B | 2.8B | 2.4B |
| Key Metrics | |||||
| Total Debt | 123.2M | 33.2M | 53.2M | 56.6M | 16.2M |
| Working Capital | 2.5B | 2.7B | 2.1B | 1.5B | 1.4B |
Balance Sheet Composition
Albert David Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 252.3M | 972.9M | 507.4M | 473.0M | 274.4M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -330.0M | 69.7M | -269.8M | 55.7M | 324.7M |
| Operating Cash Flow | -111.1M | 1.0B | 208.9M | 499.6M | 573.7M |
| Investing Activities | |||||
| Capital Expenditures | -145.7M | -108.7M | -48.3M | -86.3M | -13.1M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | -409.0M | -62.8M | -417.3M | -401.1M |
| Investment Sales | 342.6M | 76.6M | 76.0M | 0 | 974.4M |
| Investing Cash Flow | 196.8M | -441.1M | -35.1M | -503.6M | 560.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -65.5M | -51.7M | -51.5M | -34.4M | -402.0K |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | -12.2M |
| Financing Cash Flow | 14.0M | -70.4M | -49.5M | -1.0M | -12.6M |
| Free Cash Flow | -432.9M | 346.3M | 52.8M | 293.3M | 349.8M |
| Net Change in Cash | 99.7M | 493.5M | 124.3M | -5.0M | 1.1B |
Cash Flow Trend
Albert David Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
44.00
Price to Book
1.08
Price to Sales
1.32
PEG Ratio
-0.17
Profitability Ratios
Profit Margin
2.98%
Operating Margin
9.34%
Return on Equity
4.38%
Return on Assets
3.36%
Financial Health
Current Ratio
3.20
Debt to Equity
10.51
Beta
0.12
Per Share Data
EPS (TTM)
₹16.88
Book Value per Share
₹690.75
Revenue per Share
₹565.29
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ALBERTDAVD | 4.1B | 44.00 | 1.08 | 4.38% | 2.98% | 10.51 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





